Caricamento...
Alpha-Synuclein as a Biomarker of Parkinson’s Disease: Good, but Not Good Enough
Parkinson’s disease (PD) is the second most common neurodegenerative disorder of the elderly, presenting primarily with symptoms of motor impairment. The disease is diagnosed most commonly by clinical examination with a great degree of accuracy in specialized centers. However, in some cases, non-cla...
Salvato in:
| Pubblicato in: | Front Aging Neurosci |
|---|---|
| Autori principali: | , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Frontiers Media S.A.
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8298029/ https://ncbi.nlm.nih.gov/pubmed/34305577 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fnagi.2021.702639 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|